We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
Cap. Flow
-$5.83B
Cap. Flow %
-5.81%
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.21B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.87B
3
WMT icon
Walmart Inc
WMT
+$831M
4
AMZN icon
Amazon
AMZN
+$692M
5
LLY icon
Eli Lilly
LLY
+$641M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Consumer Discretionary 11.57%
3 Healthcare 9.79%
4 Financials 6.87%
5 Industrials 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSAT icon
2226
Globalstar
GSAT
$10.2B
$773K ﹤0.01%
11,637
-12,939
-53% -$789K
CB icon
2227
Chubb
CB
$140B
$772K ﹤0.01%
+2,368
New +$760K
AEM icon
2228
PUT
Agnico Eagle Mines
AEM
$72.6B
$771K ﹤0.01%
3,800
+3,700
+3,700% +$770K
CMPR icon
2229
Cimpress
CMPR
$2.37B
$771K ﹤0.01%
+10,556
New +$780K
TDW icon
2230
Tidewater
TDW
$3.91B
$770K ﹤0.01%
9,219
+3,064
+50% +$213K
BMBL icon
2231
Bumble
BMBL
$367M
$768K ﹤0.01%
235,555
-282,815
-55% -$940K
XEL icon
2232
Xcel Energy
XEL
$51B
$765K ﹤0.01%
9,633
-18,217
-65% -$1.43M
BNTC icon
2233
Benitec Biopharma
BNTC
$394M
$765K ﹤0.01%
71,832
+36,144
+101% +$418K
CDW icon
2234
CDW
CDW
$17.1B
$764K ﹤0.01%
6,316
-32,100
-84% -$4.06M
ZUMZ icon
2235
Zumiez
ZUMZ
$320M
$763K ﹤0.01%
34,437
-209,370
-86% -$5.1M
SGP
2236
SpyGlass Pharma
SGP
$685M
$760K ﹤0.01%
+29,348
New +$790K
PCYO icon
2237
Pure Cycle
PCYO
$257M
$760K ﹤0.01%
75,518
+39,137
+108% +$424K
UWMC icon
2238
UWM Holdings
UWMC
$621M
$759K ﹤0.01%
209,656
-1,071,248
-84% -$4.93M
CWCO icon
2239
Consolidated Water Co
CWCO
$469M
$758K ﹤0.01%
+22,900
New +$821K
GLXY
2240
Galaxy Digital Inc
GLXY
$4.34B
$758K ﹤0.01%
41,100
-570,823
-93% -$13.6M
MTCH icon
2241
Match Group
MTCH
$8.84B
$758K ﹤0.01%
+24,685
New +$770K
BLKB icon
2242
Blackbaud
BLKB
$1.5B
$756K ﹤0.01%
19,577
-143,537
-88% -$7.17M
PKE icon
2243
Park Aerospace
PKE
$745M
$755K ﹤0.01%
27,591
-23,483
-46% -$601K
NGEN
2244
NervGen Pharma
NGEN
$173M
$755K ﹤0.01%
+200,359
New +$868K
U icon
2245
PUT
Unity
U
$12.5B
$755K ﹤0.01%
34,400
+24,900
+262% +$691K
BRSL
2246
Brightstar Lottery PLC
BRSL
$1.91B
$754K ﹤0.01%
59,160
+8,512
+17% +$117K
CORT icon
2247
Corcept Therapeutics
CORT
$10.2B
$753K ﹤0.01%
+18,692
New +$699K
ITRN icon
2248
Ituran Location and Control
ITRN
$1.08B
$751K ﹤0.01%
+15,319
New +$722K
BBSI icon
2249
Barrett Business Services
BBSI
$976M
$750K ﹤0.01%
+25,699
New +$849K
OZK icon
2250
Bank OZK
OZK
$5.49B
$750K ﹤0.01%
16,336
-66,238
-80% -$3.12M

Similar funds

Marshall Wace's Q1 2026 Portfolio in Review

As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.

  • Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
  • Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
  • Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
  • Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
  • Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
  • Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
  • Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.